Amero Joins CSRDr. Sally A. Amero recently joined the Center for Scientific Review as a scientific review administrator in the genetic sciences initial review group. Her expertise is in molecular genetics especially recombinant DNA technology and gene cloning protein synthesis, chromosomes, transcription, RNA processing, human genetics and human gene therapy. At CSR, she will manage review of grant applications for the Small Business Innovation Research and Technology Transfer programs. Amero received her Ph.D. in genetics and developmental biology from West Virginia University. Prior to joining CSR, she held appointments at the University of Virginia, Washington University in St. Louis, and Loyola University, Chicago.
Tompkins New NIGMS Program DirectorNeurogeneticist Dr. Laurie Tompkins has joined NIGMS as a program director in the Division of Genetics and Developmental Biology, where she will manage a portfolio of grants covering the area of transcriptional regulatory proteins. She comes to NIGMS from Temple University, where she has been a professor of biology since 1992. She began her studies on the sexual behavior of fruit flies in 1977, when she joined Dr. Jeffrey Hall's laboratory at Brandeis University as a postdoctoral fellow. In 1981, she became a faculty member at Temple. During that time, she also served on the faculty at Woods Hole Marine Biology Laboratory, where she participated in a course on neural systems and behavior from 1985 to 1988.
White Heads New NCI OfficeDr. Jeffery D. White has been named director of NCI's new Office of Complementary and Alternative Medicine. A graduate of Cornell University and Howard University College of Medicine, he trained in internal medicine, oncology and hematology at Washington Hospital Center. From 1990 to 1993, he was a clinical associate in the Metabolism Branch, NCI, and subsequently served there as a staff fellow. For the past year, he has been director of the Clinical Trials Program in the Metabolism Branch. White has been interested in alternative and complementary approaches to therapy and has served as an oncology consultant to the NIH Office of Alternative Medicine. He will be NCI's liaison to OAM's successor, the new National Center for Complementary and Alternative Medicine.
Up to Top